A Machine Learning based model for a Dose Point Kernel calculation
Author:
Scarinci Ignacio Emanuel1ORCID, Valente Mauro1ORCID, Pérez Pedro1
Affiliation:
1. Universidad Nacional de Córdoba Facultad de Matemática Astronomía y Física: Universidad Nacional de Cordoba Facultad de Matematica Astronomia y Fisica
Abstract
Abstract
Purpose:
Absorbed dose calculation by kernel convolution requires the prior determination of dose point kernels (DPK). This study shows applications of machine learning to generate the DPKs for monoenergetic sources and a model to obtain DPKs for beta emitters.
Methods:
DPK for monoenergetic electron sources were calculated using the FLUKA Monte Carlo (MC) code for many materials of clinical interest and initial energies ranging from 10 to 3000 keV. Three machine learning (ML) algorithms were trained using the MC DPKs. Electron monoenergetic scaled DPKs (sDPKs) were used to assess the corresponding sDPKs for beta emitters typically used in nuclear medicine, which were compared against reference published data. Finally, the ML sDPK approach was applied to a patient-specific case calculating the dose voxel kernels (DVK) for a hepatic radioembolization treatment with \(^{90}\)Y.
Results:
The three trained machine learning models demonstrated a promising capacity to predict the sDPK for both monoenergetic emissions and beta emitters of clinical interest attaining differences lower than \(10%\) in the mean average percentage error (MAPE) as compared with previous studies. Furthermore, differences lower than \(7 %\) were obtained for the absorbed dose in patient-specific dosimetry comparing against full stochastic MC calculations.
Conclusion:
An ML model was developed to assess dosimetry calculations in nuclear medicine. The implemented approach has shown the capacity to accurately predict the sDPK for monoenergetic beta sources in a wide range of energy in different materials. The ML model to calculate the sDPK for beta-emitting radionuclides allowed to obtain VDK useful to achieve reliable patient-specific absorbed dose distributions required remarkable short computation times.
Publisher
Research Square Platform LLC
Reference74 articles.
1. Goetz, Laura H. and Schork, Nicholas J. (2018) Personalized medicine: motivation, challenges, and progress. Fertility and Sterility 109(6): 952--963 https://doi.org/10.1016/j.fertnstert.2018.05.006, Fertility and Sterility, 00150282 2. Morganti, Stefania and Tarantino, Paolo and Ferraro, Emanuela and D ’Amico, Paolo and Duso, Bruno Achutti and Curigliano, Giuseppe Next Generation Sequencing ({NGS}): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer. In: Ruiz-Garcia, Erika and Astudillo-de la Vega, Horacio (Eds.) Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics, Series Title: Advances in Experimental Medicine and Biology, 10.1007/978-3-030-24100-1_2, 2019, Springer International Publishing, 9--30, 978-3-030-24099-8 978-3-030-24100-1, 1168, Cham 3. Cooper-{DeHoff}, Rhonda M. and Johnson, Julie A. (2016) Hypertension pharmacogenomics: in search of personalized treatment approaches. Nature Reviews Nephrology 12(2): 110--122 https://doi.org/10.1038/nrneph.2015.176, Nat Rev Nephrol, 1759-5061, 1759-507X 4. Morand, Susan and Devanaboyina, Monika and Staats, Hannah and Stanbery, Laura and Nemunaitis, John (2021) Ovarian Cancer Immunotherapy and Personalized Medicine. International Journal of Molecular Sciences 22(12): 6532 https://doi.org/10.3390/ijms22126532, {IJMS}, 1422-0067 5. Ho, Dean and Quake, Stephen R. and {McCabe}, Edward R.B. and Chng, Wee Joo and Chow, Edward K. and Ding, Xianting and Gelb, Bruce D. and Ginsburg, Geoffrey S. and Hassenstab, Jason and Ho, Chih-Ming and Mobley, William C. and Nolan, Garry P. and Rosen, Steven T. and Tan, Patrick and Yen, Yun and Zarrinpar, Ali (2020) Enabling Technologies for Personalized and Precision Medicine. Trends in Biotechnology 38(5): 497--518 https://doi.org/10.1016/j.tibtech.2019.12.021, Trends in Biotechnology, 01677799
|
|